CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
is superior to placebo on change from baseline of the Preclinical Alzheimer Cognitive Composite 5 (PACC5) at 216 weeks of treatment (A45 Tri...
Phase 3
Nashville, Tennessee, United States and 111 other locations
Alzheimer's disease (AD) is a progressive, irreversible neurological disorder and is the most common cause of dementia in the elder...
Phase 2
Nashville, Tennessee, United States and 63 other locations
study is to assess the effectiveness, safety, and tolerability of BMS-986446 an Anti-MTBR Tau Monoclonal Antibody in participants with Early Alzheimer's...
Phase 2
Franklin, Tennessee, United States and 183 other locations
outpatient study in subjects with psychosis associated with Alzheimer's Disease.The primary objective of the study is to evaluate r ...
Phase 3
Franklin, Tennessee, United States and 76 other locations
A 76-week safety and efficacy study of simufilam (PTI-125) given twice daily to participants with mild-to-moderate Alzheimer's disease...
Phase 3
Franklin, Tennessee, United States and 89 other locations
This project will investigate the potential of Deep Brain Stimulation to improve cognitive abilities and counteract the effects of Alzheimer's...
Nashville, Tennessee, United States
This study is done to find out whether the medicine, semaglutide, has a positive effect on early Alzheimer's disease.Participants w...
Phase 3
Nashville, Tennessee, United States and 343 other locations
This study is done to find out whether the medicine, semaglutide, has a positive effect on early Alzheimer's disease.Participants w...
Phase 3
Nashville, Tennessee, United States and 382 other locations
This study is being conducted to evaluate the safety and efficacy of ALZ-801 in Early Alzheimer's disease (AD) subjects with the AP...
Phase 3
Nashville, Tennessee, United States and 94 other locations
This is an extension study of the Phase 3 Studies 15-AVP-786-301, 15-AVP-786-302, and 17-AVP-786-305, which also allows participants from the Phase 2...
Phase 3
Franklin, Tennessee, United States and 274 other locations
Clinical trials
Research sites
Resources
Legal